Overview

Performance
Performance
-
Returns
| 1y | 3y | 5y | 10y | |
|---|---|---|---|---|
|
Total Return (%)
as of Dec 31, 2025 |
21.23 | 14.16 | 11.29 | 10.79 |
|
Return w/ Sales Charge (%)
as of Dec 31, 2025 |
17.59 | 13.01 | 10.61 | 10.46 |
|
Benchmark (%)
as of Dec 31, 2025 |
15.91 | 13.90 | 11.33 | 10.53 |
| YTD | 1m | 3m | 1y | 3y | 5y | 10y | |
|---|---|---|---|---|---|---|---|
|
Total Return (%)
as of Dec 31, 2025 |
21.23 | 1.97 | 5.01 | 21.23 | 48.80 | 70.68 | 178.73 |
|
Return w/ Sales Charge (%)
as of Dec 31, 2025 |
17.59 | -1.09 | 1.86 | 17.59 | 44.33 | 65.56 | 170.37 |
|
Benchmark (%)
as of Dec 31, 2025 |
15.91 | 0.68 | 3.81 | 15.91 | 47.76 | 70.99 | 172.13 |
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Total Return (%) | 19.91 | -4.34 | 12.27 | 9.33 | 21.23 |
| Annual w/ Sales Charge (%) | 13.61 | -9.36 | 8.90 | 6.05 | 17.59 |
| Benchmark (%) | 25.16 | -7.54 | 11.46 | 14.37 | 15.91 |
Performance is shown after deduction of ongoing charges. Any entry and exit charges are excluded from the calculation.
Key Facts
Key Facts
Portfolio Characteristics
Portfolio Characteristics
Fees
Fees
| Gross Expense Ratio | 1.08% |
| Net Expense Ratio | 1.08% |
Net Expense Ratio excluding Investment Related Expenses is 0.39%
- Acquired Fund Fees and Expenses 0.69%
- Interest expense 0.00%
Holdings
Holdings
| Name | Weight (%) |
|---|---|
| CITIGROUP INC | 3.36 |
| WELLS FARGO & COMPANY | 3.27 |
| CARDINAL HEALTH INC | 2.81 |
| SS&C TECHNOLOGIES HOLDINGS INC | 2.62 |
| AMAZON.COM INC | 2.58 |
| Name | Weight (%) |
|---|---|
| BECTON DICKINSON AND COMPANY | 2.44 |
| FIRST CITIZENS BANCSHARES INC (DELAWARE) | 2.33 |
| INTERCONTINENTAL EXCHANGE INC | 2.21 |
| MEDTRONIC PLC | 2.19 |
| CVS HEALTH CORP | 2.13 |
Exposure Breakdowns
Exposure Breakdowns
Allocations are subject to change.
Portfolio Managers
Portfolio Managers
ESG Integration
ESG Integration
This fund does not seek to follow a sustainable, impact or ESG investment strategy. For more information regarding the fund's investment strategy, please see the fund's prospectus or, as applicable, shareholder report.